Xenon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -659 | -599 | ||
EBITDA | -76,844 | -73,007 | -68,445 | -58,442 |
EBIT | -77,477 | -73,676 | -69,104 | -59,041 |
Net Income | -65,685 | -62,790 | -57,924 | -47,931 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -55,168 | -51,737 | -34,193 | -43,366 |
Cash | 142,712 | 87,621 | 136,734 | 58,896 |
Basic Shares | 78,386 | 77,926 | 77,671 | 77,594 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $9,434 | $18,437 |
Gross Profit | -167,512 | 9,434 | 18,437 | |
EBITDA | -279,298 | -210,513 | -127,519 | -78,087 |
EBIT | -214,054 | -129,143 | -78,993 | |
Net Income | -234,330 | -182,393 | -125,373 | -78,882 |
Net Change In Cash | 0 | 0 | 9,434 | 18,437 |
Cost of Revenue | -115,962 | 131,271 | ||
Free Cash Flow | -181,389 | -150,944 | -101,324 | -71,552 |
Cash | 142,712 | 148,643 | 57,242 | 175,688 |
Basic Shares | 77,894 | 66,889 | 60,542 | 43,627 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.84 |
2024-09-30 | -$0.81 |
2024-06-30 | -$0.75 |
2024-03-31 | -$0.62 |
